Brian M. Hahn
2013
In 2013, Brian M. Hahn earned a total compensation of $260.4K as Chief Financial Officer at GlycoMimetics.
Compensation breakdown
| Non-Equity Incentive Plan | $43,750 |
|---|---|
| Salary | $216,667 |
| Total | $260,417 |
Hahn received $216.7K in salary, accounting for 83% of the total pay in 2013.
Hahn also received $43.8K in non-equity incentive plan.
Rankings
In 2013, Brian M. Hahn's compensation ranked 11,142nd out of 12,286 executives tracked by ExecPay. In other words, Hahn earned more than 9.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,142 out of 12,286 | 9th |
Division Manufacturing | 4,181 out of 4,612 | 9th |
Major group Chemicals And Allied Products | 1,326 out of 1,462 | 9th |
Industry group Drugs | 1,052 out of 1,156 | 9th |
Industry Pharmaceutical Preparations | 814 out of 890 | 9th |
Source: SEC filing on June 15, 2015.
Hahn's colleagues
We found three more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2013.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019